- Global Pharma News & Resources

The Cystic Fibrosis Testing Market to explode between 2020 and 2030

Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.

For more insights into the Market, request a sample of this report @

Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.

For Information On The Research Methodology request here @

Geographically, North America, especially the U.S. dominates the cystic fibrosis testing market followed by the European market. Major factors responsible for the growth of this market in these regions include high prevalence of genetic disorders, such as, respiratory disorders, decreased mucociliary clearance and frameshift mutation in the gene CFTR (cystic fibrosis transmembrane conductance regulator). About 10,000 new cases of cystic fibrosis are diagnosed every year in the U.S. Other factors driving the growth in this market include high awareness about healthcare in these regions and also the rising demand for efficient cystic fibrosis testing. With the introduction of genetic testing, there is a huge scope for this market to excel in the near future with more innovative researches. Asia-Pacific is the most lucrative market as this region is expected to show a rapid growth in future. Major factors responsible for the rapid growth of this market in the region are presence of large population of patients with increasing awareness about cystic fibrosis and its diagnostic methods, increasing income of the population will also accentuate the growth of this market in this region. This market is also expected to show a rapid growth in this region due to factors like improved healthcare infrastructure and demand for advanced testing tools.

To receive extensive list of important regions, Request TOC here @

Some of the major players operating in the cystic fibrosis testing market are Vertex Pharmaceuticals, Abbott Laboratories, Inc., Pfizer, Inc., NovaBiotics Ltd., Cystic Fibrosis Foundation Therapeutics, Inc., and Galapagos NV.

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws on its multi-disciplinary capabilities and high pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us:

Sourabh KJ

305 Broadway

7th Floor

New York City, NY 10007

United States

USA – Canada Toll-Free: 800-961-0353




Editor Details

Last Updated: 09-Nov-2020